JPRN-UMIN000054123招募中未知
Exploring the effects of suvorexant on sleep and blood biomarkers in Alzheimer's disease - Exploring the effects of suvorexant on sleep and blood biomarkers in Alzheimer's disease
Kurita hospital0 个研究点目标入组 15 人开始时间: 2024年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, Comorbid dementia other than Alzheimer's disease. 2, Comorbid schizophrenia, mood disorder, anxiety disorder, drug/substance addiction, or personality disorder. 3, Serious physical illnesses such as cerebrovascular disease, cardiac disease, renal dysfunction, and neurological disease. 4, The patient has a coexisting sleep-related breathing disorder (respiratory event index of 10 or more on the apnomonitor). 5, The principal investigator or attending physician determines that the subject is unsuitable for the study.
研究者
相似试验
招募中
不适用
The effects of suvorexant on sleep disorder and clinical findings of hemodialysis patientsInsomnia, maintenance hemodialysis patientJPRN-UMIN000023199Toda Central General Hospital50
招募中
不适用
Effects of Suvorexant on sleep disorder and BPSD(Behavioral and Psychological Symptoms of Dementia) of Alzheimer's diseaseAlzheimer's diseaseJPRN-UMIN000018127Department of Psychiatry, Jikei university school of medicine40
已完成
4 期
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 DiabetesSleep DisorderInflammationType 2 Diabetes MellitusInsomniaNCT03818581Massachusetts General Hospital108
已完成
4 期
Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic InsomniaRestless Legs SyndromeSleep DisorderInsomniaNCT04706091Massachusetts General Hospital46
终止
2 期
The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use DisorderMethamphetamine Use DisorderNCT05711862The University of Texas Health Science Center, Houston7